Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12507
Title: The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
Austin Authors: Klunk, William E;Koeppe, Robert A;Price, Julie C;Benzinger, Tammie L;Devous, Michael D;Jagust, William J;Johnson, Keith A;Mathis, Chester A;Minhas, Davneet;Pontecorvo, Michael J;Rowe, Christopher C ;Skovronsky, Daniel M;Mintun, Mark A
Affiliation: Department of Radiology, UT Southwestern Medical Center, Dallas, TX, USA
Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA
Department of Radiology, University of Michigan, Ann Arbor, MI, USA
Department of Neurology, University of Pittsburgh, Pittsburgh. PA, USA
Department of Radiology, Massachusetts General Hospital, Boston, MA, USA
Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia, Australia
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
Departments of Radiology, Pharmacology and Biological Chemistry, and Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA
Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, CA, USA
Department of Neurosurgery, Washington University, Saint Louis, MO, USA
Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
Avid Radiopharmaceuticals, Philadelphia, PA, USA
Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA
Issue Date: 28-Oct-2014
Publication information: Alzheimer's & Dementia : the Journal of the Alzheimer's Association 2014; 11(1): 1-15.e1-4
Abstract: Although amyloid imaging with PiB-PET ([C-11]Pittsburgh Compound-B positron emission tomography), and now with F-18-labeled tracers, has produced remarkably consistent qualitative findings across a large number of centers, there has been considerable variability in the exact numbers reported as quantitative outcome measures of tracer retention. In some cases this is as trivial as the choice of units, in some cases it is scanner dependent, and of course, different tracers yield different numbers. Our working group was formed to standardize quantitative amyloid imaging measures by scaling the outcome of each particular analysis method or tracer to a 0 to 100 scale, anchored by young controls (≤ 45 years) and typical Alzheimer's disease patients. The units of this scale have been named "Centiloids." Basically, we describe a "standard" method of analyzing PiB PET data and then a method for scaling any "nonstandard" method of PiB PET analysis (or any other tracer) to the Centiloid scale.
Gov't Doc #: 25443857
URI: http://ahro.austin.org.au/austinjspui/handle/1/12507
DOI: 10.1016/j.jalz.2014.07.003
URL: https://pubmed.ncbi.nlm.nih.gov/25443857
Type: Journal Article
Subjects: Amyloid imaging
Centiloid scale
Pittsburgh compound B
Positron emission tomography
Standardize
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Dec 4, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.